IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Strategies for Generic and Branded Drug Firms Converge

11:17 AM MDT | October 3, 2007 | Alex Scott

Generics drug companies and branded drug producers are reassessing their respective manufacturing strategies in light of tightening competition in the sector, according to a recent report by Enrico T. Polastro, v.p. and senior industry specialist at Arthur D. Little Benelux (Brussels). Generics firms typically outsource their bulk manufacturing, and branded drug producers retain much of their manufacturing in-house, Polastro says. However, the two distinct models have started to converge as producers attempt to gain a competitive edge through enhanced bulk...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa